1. Home
  2. VVOS vs EVGN Comparison

VVOS vs EVGN Comparison

Compare VVOS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.80

Market Cap

11.6M

Sector

Health Care

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.75

Market Cap

9.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
EVGN
Founded
2016
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
9.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
VVOS
EVGN
Price
$0.80
$0.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.75
$3.50
AVG Volume (30 Days)
277.9K
43.7K
Earning Date
04-15-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
N/A
N/A
Revenue
$17,443,000.00
N/A
Revenue This Year
$69.66
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
16.05
N/A
52 Week Low
$0.81
$0.72
52 Week High
$7.40
$2.42

Technical Indicators

Market Signals
Indicator
VVOS
EVGN
Relative Strength Index (RSI) 31.74 39.28
Support Level N/A $0.72
Resistance Level $1.50 $1.23
Average True Range (ATR) 0.11 0.05
MACD -0.03 -0.00
Stochastic Oscillator 2.62 13.36

Price Performance

Historical Comparison
VVOS
EVGN

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: